Stockscreener 앱 받기
3.45
0.28%
0.12
전일 마감가:
$3.57
열려 있는:
$3.57
하루 거래량:
14,550
Relative Volume:
0.18
시가총액:
$135.84M
수익:
$15.33M
순이익/손실:
$-40.19M
주가수익비율:
-1.969
EPS:
-1.7522
순현금흐름:
-
1주 성능:
-14.96%
1개월 성능:
-26.79%
6개월 성능:
-36.19%
1년 성능:
-38.70%
1일 변동 폭
$3.42
$3.62
1주일 범위
$3.42
$4.25
52주 변동 폭
$3.42
$6.04
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
명칭
Trisalus Life Sciences Inc
전화
415 336 8917
주소
6272 WEST 91ST AVENUE, WESTMINSTER
TLSI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
3.59 | 150.00M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
129.96 | 233.71B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.44 | 152.83B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.46 | 144.35B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.17 | 119.00B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.36 | 46.00B | 5.69B | 4.14B | 577.90M | 6.96 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-13 | 개시 | Lake Street | Buy |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-11 | 개시 | ROTH MKM | Buy |
| 2024-10-25 | 개시 | Northland Capital | Outperform |
| 2024-09-16 | 개시 | Oppenheimer | Outperform |
| 2024-05-30 | 개시 | Canaccord Genuity | Buy |
모두보기
Trisalus Life Sciences Inc 주식(TLSI)의 최신 뉴스
Can TriSalus Life Sciences Inc. Equity Warrant rally from current levelsHigh Return Idea With Technical Filter - Newser
Analyzing recovery setups for TriSalus Life Sciences Inc. investorsSteady Return Plan Based on Data Analysis - Newser
Can trapped investors hope for a rebound in TriSalus Life Sciences Inc.Free Reliable Alerts for Daily Stock Movers - Newser
Chart based analysis of TriSalus Life Sciences Inc. Equity Warrant trendsConservative Investment Setup and Risk Analysis - Newser
TriSalus Life Sciences Inc. Equity Warrant stock trend outlook and recovery pathTechnical Reversal Setup with Risk Limits - Newser
Using RSI to spot recovery in TriSalus Life Sciences Inc. Equity WarrantPredictive AI Signals for Short-Term Trading - Newser
Chart based exit strategy for TriSalus Life Sciences Inc. Equity WarrantHigh Win Rate Strategy with Stop Protection - Newser
Is this a good reentry point in TriSalus Life Sciences Inc.Portfolio Review Summary with Five-Year Outlook - Newser
Detecting support and resistance levels for TriSalus Life Sciences Inc.Momentum Trading Guide with Safety Limits - Newser
TriSalus study shows promising results for thyroid disease treatment - Investing.com
Breakthrough Thyroid Procedure Achieves 73% Size Reduction: New Clinical Data Reveals Game-Changing Results - Stock Titan
Is TriSalus Life Sciences Inc. Equity Warrant stock entering bullish territoryDaily Upside Movement Prediction With Data - Newser
Why TriSalus Life Sciences Inc. stock attracts strong analyst attentionTrading Watchlist with Real Time Filters - Newser
Applying big data sentiment scoring on TriSalus Life Sciences Inc. Equity WarrantLong-Term Allocation Strategy Summary Breakdown - Newser
Published on: 2025-08-11 02:05:07 - Newser
Published on: 2025-08-10 22:56:45 - Newser
Has TriSalus Life Sciences Inc. Equity Warrant formed a bullish divergencePortfolio Allocation Strategy for Stability - Newser
Is TriSalus Life Sciences Inc. Equity Warrant Stock a Good Fit for Conservative InvestorsRisk-Managed Strategy Based on Price Analysis - Newser
Order flow analysis tools used on TriSalus Life Sciences Inc. Equity WarrantFree Long Hold Safe Return Strategy - Newser
Understanding TriSalus Life Sciences Inc. Equity Warrant’s price movementFree Risk Adjusted Technical Entry Plan - Newser
News impact scoring models applied to TriSalus Life Sciences Inc.ROI Prediction from Long-Term Holding Plans - Newser
Applying sector rotation models to TriSalus Life Sciences Inc. Equity WarrantFree High Yield Stocks With Buy Confirmation - Newser
Applying big data sentiment scoring on TriSalus Life Sciences Inc.5-Year Price Trend Summary and Analysis - Newser
Can TriSalus Life Sciences Inc. Rally Enough to Break EvenExpert Verified Stock Trade Ideas Backed by Data - beatles.ru
Will TriSalus Life Sciences Inc. price bounce be sustainableCapital Protection Strategy With Risk Analysis - Newser
Is TriSalus Life Sciences Inc. trending in predictive chart modelsBuy and Hold Strategy for Capital Safety - Newser
Will TriSalus Life Sciences Inc. see short term momentumBuy Strategy Review With Performance Summary - Newser
What makes TriSalus Life Sciences Inc. Equity Warrant stock price move sharplyFree AI Driven Stock Trend Forecast - Newser
Earnings Preview: TLSI to Report Financial Results Post-market on August 12 - 富途牛牛
TriSalus Life Sciences Inc. Equity Warrant stock outlook for YEARAccurate Forecast System with AI Support - Newser
Applying Wyckoff theory to TriSalus Life Sciences Inc. stockDaily Upside Movement Prediction With Data - Newser
TriSalus Bets Big On Growing Its Cancer Device Platform - Finimize
Forecasting TriSalus Life Sciences Inc. Equity Warrant price range with options dataFree AI Screening for Swing Trade Picks - Newser
News impact scoring models applied to TriSalus Life Sciences Inc. Equity WarrantInvestment Timing Strategy with Market Filters - Newser
Can TriSalus Life Sciences Inc. Regain Momentum After BreakdownCapital Preserving Trade Plan Templates Shared - beatles.ru
When is the best time to exit TriSalus Life Sciences Inc. Equity WarrantFree Consistent Income Focused Trade List - Newser
Should I hold or sell TriSalus Life Sciences Inc. stock in 2025Capitalize on emerging market trends - Jammu Links News
What are the latest earnings results for TriSalus Life Sciences Inc. Equity WarrantRapid wealth accumulation - Jammu Links News
How does TriSalus Life Sciences Inc. compare to its industry peersTriple-digit wealth increases - Jammu Links News
What is TriSalus Life Sciences Inc. company’s growth strategyRobust investment performance - Jammu Links News
When is TriSalus Life Sciences Inc. stock expected to show significant growthBuild a diversified portfolio for steady growth - Jammu Links News
What are the technical indicators suggesting about TriSalus Life Sciences Inc. Equity WarrantOutstanding capital returns - Jammu Links News
Why is TriSalus Life Sciences Inc. Equity Warrant stock attracting strong analyst attentionUnlock real-time stock alerts for quick profits - Jammu Links News
What are analysts’ price targets for TriSalus Life Sciences Inc. in the next 12 monthsRapid profit acceleration - Jammu Links News
What is the risk reward ratio of investing in TriSalus Life Sciences Inc. stockDouble-digit growth - Jammu Links News
What is the dividend policy of TriSalus Life Sciences Inc. stockBuild a diversified portfolio for risk mitigation - Jammu Links News
What is TriSalus Life Sciences Inc. Equity Warrant company’s growth strategyFree Capital Allocation Plans - Jammu Links News
Does TriSalus Life Sciences Inc. Equity Warrant fit your quant trading modelTen-Year Sector Performance and Summary Analysis - Newser
TriSalus Life Sciences Inc. Equity Warrant Stock Analysis and ForecastCapitalize on high-yield stock opportunities - Jammu Links News
How volatile is TriSalus Life Sciences Inc. stock compared to the marketGet timely market insights for better trades - Jammu Links News
What drives TriSalus Life Sciences Inc. stock priceCapitalize on market trends with expert guidance - Jammu Links News
Trisalus Life Sciences Inc (TLSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Trisalus Life Sciences Inc 주식 (TLSI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Devlin Jodi | Chief of Clinical Operations |
May 19 '25 |
Sale |
5.18 |
4,764 |
24,678 |
52,764 |
| Marshak Richard | Chief Commercial Officer |
May 19 '25 |
Sale |
5.18 |
6,597 |
34,172 |
69,101 |
| Stevens Jennifer | Chief Regulatory Officer |
May 19 '25 |
Sale |
5.18 |
8,704 |
45,087 |
77,640 |
| Young James Emmett | Chief Financial Officer |
Feb 05 '25 |
Buy |
5.65 |
6,000 |
33,900 |
30,000 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 30 '25 |
Buy |
5.28 |
5,010 |
26,453 |
444,259 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 29 '25 |
Buy |
5.03 |
5,030 |
25,301 |
439,249 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 27 '25 |
Buy |
5.42 |
4,826 |
26,157 |
429,503 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 28 '25 |
Buy |
5.12 |
4,716 |
24,146 |
434,219 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 27 '25 |
Buy |
5.31 |
15,000 |
79,650 |
182,732 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 28 '25 |
Buy |
5.17 |
15,000 |
77,550 |
197,732 |
0.30%
0.92%
자본화:
|
볼륨(24시간):